Related Experiment Video

Updated: Jun 4, 2026

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors
19:02

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors

Published on: March 22, 2011

Adenovirus-mediated drug-sensitivity gene therapy for hepatocellular carcinoma

F Kanai1, M Ohashi, P A Marignani

  • 1Department of Cell Biology, Harvard Medical School, Boston, MA.

Methods in Molecular Medicine
|February 23, 2011
PubMed

Insights

Selective gene therapy uses nontoxic suicide genes for cancer treatment. These genes activate prodrugs into cell-killing compounds, offering a targeted therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Selective gene therapy is a promising cancer treatment modality.
  • It leverages endogenous nontoxic suicide genes within cells.
  • Current strategies involve viral or bacterial enzymes to activate prodrugs.

Purpose of the Study:

  • To explore the mechanism of selective gene therapy in cancer treatment.
  • To highlight the role of suicide genes in mediating drug sensitivity.

Main Methods:

  • Investigating suicide genes that encode specific enzymes.
  • Analyzing the conversion of inactive prodrugs to toxic antimetabolites.
  • Focusing on antimetabolites that inhibit nucleic acid synthesis.

Main Results:

  • Suicide genes confer sensitivity by producing enzymes.
  • These enzymes transform prodrugs into cytotoxic agents.
  • The resulting antimetabolites disrupt nucleic acid synthesis, leading to cell death.

Conclusions:

  • Selective gene therapy offers a targeted approach to cancer treatment.
  • The utilization of suicide genes enhances the efficacy of prodrug-based therapies.
  • This strategy holds potential for developing novel cancer therapeutics.

More Related Videos

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine09:54

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting08:14

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting

Published on: October 26, 2018

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...